Tech Company Financing Transactions

Esperance Pharmaceuticals Funding Round

BVM Capital, Louisiana Fund and RCT BioVentures participated in a $9 million Series A funding round for Esperance Pharmaceuticals. The funding round was announced by the company on 10/31/2006.

Transaction Overview

Company Name
Esperance Pharmaceuticals
Announced On
10/31/2006
Transaction Type
Venture Equity
Amount
$9,000,000
Round
Series A
Investors

BVM Capital (Lead Investor) (Ross Barrett)

Louisiana Fund (Lead Investor) (Joseph Lovett)

RCT BioVentures (Lead Investor) (Chad Souvignier)

Proceeds Purpose
Esperance will use the Series A funding to identify a lead compound, establish an assay to select candidate patients and conduct a proof-of-concept study in humans with cancer.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
909 Fannin St. 2000
Houston, TX 77010
USA
Phone
Undisclosed
Website
www.esperancepharma.com
Email Address
Not Recorded
Overview
Esperance Pharmaceuticalsdevelops anticancer drugsthat kill cancer cells without harming normal cells.
Profile
Esperance Pharmaceuticals LinkedIn Company Profile
Social Media
Esperance Pharmaceuticals Company Twitter Account
Company News
Esperance Pharmaceuticals News
Facebook
Esperance Pharmaceuticals on Facebook
YouTube
Esperance Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Hector Alila
  Hector Alila LinkedIn Profile  Hector Alila Twitter Account  Hector Alila News  Hector Alila on Facebook
Chief Financial Officer
Clarice Motter
  Clarice Motter LinkedIn Profile  Clarice Motter Twitter Account  Clarice Motter News  Clarice Motter on Facebook
VP - R & D
Carola Leuschner
  Carola Leuschner LinkedIn Profile  Carola Leuschner Twitter Account  Carola Leuschner News  Carola Leuschner on Facebook

 

 

Browse more venture capital transactions:

Prev: 10/31/2006: LevelVision venture capital transaction
Next: 10/31/2006: Veveo venture capital transaction

 

Share this article

 

News on VC Transactions

We do our best to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.